PEPTIDES (peptides containing -lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D 519/02; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N 15/00)
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| 8,663,643 | Combinations of an anti-HER2 antibody-drug conjugate and chemotherapeutic agents, and methods of use | Mar 10, 09 | Mar 04, 14 | GENENTECH, INC. |
| 8,663,675 | Injectable matrix having a polymer and a stem cell niche composed of cup-shaped nanoparticles containing growth factors or physiological agents for organ reconstruction | Nov 18, 10 | Mar 04, 14 | Not available |
| 8,663,950 | Production of a monoclonal antibody therapeutic against west nile virus in plants | Jan 10, 11 | Mar 04, 14 | ARIZONA BOARD OF REGENTS |
| 8,663,990 | Measurement method utilizing internal standard substance | Apr 27, 10 | Mar 04, 14 | WAKO PURE CHEMICAL INDUSTRIES, LTD. |
| 8,664,179 | Identification of novel antagonist toxins of T-type calcium channel for analgesic purposes | Jan 15, 10 | Mar 04, 14 | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS); UNIVERSITE DE NICE - SOPHIA ANTIPOLIS; |
| 8,664,181 | Dual acting prodrugs | Feb 15, 08 | Mar 04, 14 | KTB TUMORFORSCHUNGSGESELLSCHAFT MBH |
| 8,664,183 | SPANX-B polypeptides and their use | Feb 26, 10 | Mar 04, 14 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES |
| 8,664,355 | Cell-free protein synthesis method with the use of linear template DNA and cell extract therefor | May 17, 07 | Mar 04, 14 | RIKEN |
| 8,664,356 | Gamma amino acid building blocks | Oct 14, 10 | Mar 04, 14 | WISCONSIN ALUMNI RESEARCH FOUNDATION |
| 8,664,357 | Solvent resistant diafiltration of peptides, PNA or oligonucleotides | Aug 07, 09 | Mar 04, 14 | IMPERIAL INNOVATIONS LIMITED |
| 8,664,358 | Predictive markers for ovarian cancer | Jun 30, 08 | Mar 04, 14 | VERMILLION, INC. |
| 8,664,359 | Cancer related isoforms of components of transcription factor complexes as biomarkers and drug targets | Jun 03, 08 | Mar 04, 14 | ONCOTX, INC. |
| 8,664,360 | BSL3 polypeptides | Dec 20, 11 | Mar 04, 14 | BRISTOLS-MYERS SQUIBB COMPANY |
| 8,664,362 | Humanized and chimeric anti-properdin antibodies | Mar 10, 11 | Mar 04, 14 | NOVELMED THERAPEUTICS, INC. |
| 8,664,363 | Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease | Feb 28, 13 | Mar 04, 14 | MEDIMMUNE, LLC |
| 8,664,364 | Optical biosensors | Jan 24, 08 | Mar 04, 14 | CARNEGIE MELLON UNIVERSITY |
| 8,664,366 | Fusion proteins forming trimers | Jan 09, 09 | Mar 04, 14 | APOGENIX GMBH |
| 8,664,368 | Fully human monoclonal antibody to VEGF, preparation method and use thereof | Apr 16, 10 | Mar 04, 14 | SHANGHAI BIOMABS PHARMACEUTICALS CO., LTD. |
| 8,664,369 | LH liquid formulations | Oct 29, 08 | Mar 04, 14 | MERCK SERONO S.A. |
| 8,664,410 | Fluorescent dye and use thereof | Jun 24, 11 | Mar 04, 14 | UNIVERSITAT POTSDAM |
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2014/0065,063 | THERAPEUTIC USE OF ANTI-CS1 ANTIBODIES | May 15, 13 | Mar 06, 14 | Not available |
| 2014/0065,064 | MONOCLONAL ANTIBODIES AGAINST ALPHA-ACTININ-4 ANTIGENS, AND USES THEREFOR | Dec 23, 11 | Mar 06, 14 | Not available |
| 2014/0065,097 | Immunotherapy | Aug 20, 13 | Mar 06, 14 | ROCHE GLYCART AG |
| 2014/0065,105 | Simian Adenovirus Nucleic Acid and Amino Acid Sequences, Vectors Containing Same, and Methods of Use | Nov 07, 13 | Mar 06, 14 | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA |
| 2014/0065,111 | Affinity Maturated T Cell Receptors And Use Thereof | Aug 02, 13 | Mar 06, 14 | Not available |
| 2014/0065,113 | GENETICALLY ENGINEERED GROWTH FACTOR VARIANTS | Nov 11, 13 | Mar 06, 14 | MINERVA BIOTECHNOLOGIES CORPORATION |
| 2014/0065,126 | BChE ALBUMIN FUSIONS FOR THE TREATMENT OF COCAINE ABUSE | Sep 04, 13 | Mar 06, 14 | TEVA PHARMACEUTICAL INDUSTRIES LTD. |
| 2014/0065,135 | METHODS OF USING ANTI-PD-L1 ANTIBODIES AND THEIR USE TO ENHANCE T-CELL FUNCTION TO TREAT TUMOR IMMUNITY | Jul 30, 13 | Mar 06, 14 | GENENTECH, INC. |
| 2014/0065,137 | HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF | Sep 20, 13 | Mar 06, 14 | GENENTECH INC. |
| 2014/0065,138 | ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF | Sep 27, 13 | Mar 06, 14 | ELI LILLY AND COMPANY |
| 2014/0065,142 | Multivalent and Monovalent Multispecific Complexes and Their Uses | Mar 15, 13 | Mar 06, 14 | ZYNGENIA, INC. |
| 2014/0065,143 | Inhibition of AXL Signaling in Anti-Metastatic Therapy | Jul 24, 13 | Mar 06, 14 | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY |
| 2014/0065,144 | USE OF IL-20 ANTAGONISTS FOR PROMOTING BONE FRACTURE HEALING | Aug 30, 12 | Mar 06, 14 | NATIONAL CHENG KUNG UNIVERSITY |
| 2014/0065,146 | ANTI-SIGLEC-15 ANTIBODY | Sep 30, 13 | Mar 06, 14 | DAIICHI SANKYO COMPANY LIMITED |
| 2014/0065,151 | ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2 | Jul 13, 12 | Mar 06, 14 | Not available |
| 2014/0065,152 | NOVEL EPITOPE FOR SWITCHING TO TH1 CELL AND USE THEREOF | Apr 12, 13 | Mar 06, 14 | NATIONAL CANCER CENTER |
| 2014/0065,154 | TLR3 BINDING AGENTS | Jan 10, 12 | Mar 06, 14 | INNATE PHARMA SA |
| 2014/0065,155 | NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE NOGO-66 RECEPTOR (NgR) AND USES THEREOF | Aug 29, 13 | Mar 06, 14 | Not available |
| 2014/0065,156 | HUMAN BINDING MOLECULES CAPABLE OF NEUTRALIZING INFLUENZA VIRUS H5N1 AND USES THEREOF | Oct 01, 13 | Mar 06, 14 | CRUCELL HOLLAND B.V. |
| 2014/0065,158 | ANTI-PROLACTIN RECEPTOR ANTIBODY FORMULATIONS | Mar 15, 13 | Mar 06, 14 | Not available |
